Literature DB >> 12354302

SEL-10 interacts with presenilin 1, facilitates its ubiquitination, and alters A-beta peptide production.

Jinhe Li1, Adele M Pauley, Rick L Myers, Rongqing Shuang, John R Brashler, Riqiang Yan, Allen E Buhl, Cara Ruble, Mark E Gurney.   

Abstract

Mutations in the human presenilin genes (PS1 or PS2) have been linked to autosomal dominant, early onset Alzheimer's disease (AD). Presenilins, probably as an essential part of gamma-secretase, modulate gamma-cleavage of the amyloid protein precursor (APP) to the amyloid beta-peptide (Abeta). Mutations in sel-12, a Caenorhabditis elegans presenilin homologue, cause a defect in egg laying that can be suppressed by loss of function mutations in a second gene, SEL-10. SEL-10 protein is a homologue of yeast Cdc4, a member of the SCF (Skp1-Cdc53/CUL1-F-box protein) E2-E3 ubiquitin ligase family. In this study, we show that human SEL-10 interacts with PS1 and enhances PS1 ubiquitination, thus altering cellular levels of unprocessed PS1 and its N- and C-terminal fragments. Co-transfection of sel-10 and APP cDNAs in HEK293 cells leads to an alteration in the metabolism of APP and to an increase in the production of amyloid beta-peptide, the principal component of amyloid plaque in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354302     DOI: 10.1046/j.1471-4159.2002.01105.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  19 in total

1.  FBL2 regulates amyloid precursor protein (APP) metabolism by promoting ubiquitination-dependent APP degradation and inhibition of APP endocytosis.

Authors:  Tomomichi Watanabe; Yukiko Hikichi; Antje Willuweit; Yasushi Shintani; Takashi Horiguchi
Journal:  J Neurosci       Date:  2012-03-07       Impact factor: 6.167

Review 2.  E3 ubiquitin ligases in protein quality control mechanism.

Authors:  Deepak Chhangani; Ajay Prakash Joshi; Amit Mishra
Journal:  Mol Neurobiol       Date:  2012-05-19       Impact factor: 5.590

3.  Presenilin modulates EGFR signaling and cell transformation by regulating the ubiquitin ligase Fbw7.

Authors:  V Rocher-Ros; S Marco; J-H Mao; S Gines; D Metzger; P Chambon; A Balmain; C A Saura
Journal:  Oncogene       Date:  2010-03-08       Impact factor: 9.867

4.  Notch signaling is antagonized by SAO-1, a novel GYF-domain protein that interacts with the E3 ubiquitin ligase SEL-10 in Caenorhabditis elegans.

Authors:  Valerie A Hale; Evan L Guiney; Lindsey Y Goldberg; Josephine H Haduong; Callie S Kwartler; Katherine W Scangos; Caroline Goutte
Journal:  Genetics       Date:  2011-12-29       Impact factor: 4.562

5.  Adaptive evolution in two large families of ubiquitin-ligase adapters in nematodes and plants.

Authors:  James H Thomas
Journal:  Genome Res       Date:  2006-07-06       Impact factor: 9.043

Review 6.  The ubiquitous nature of cancer: the role of the SCF(Fbw7) complex in development and transformation.

Authors:  K M Crusio; B King; L B Reavie; I Aifantis
Journal:  Oncogene       Date:  2010-06-14       Impact factor: 9.867

Review 7.  Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system.

Authors:  Collin Y Ewald; Chris Li
Journal:  Brain Struct Funct       Date:  2009-12-11       Impact factor: 3.270

8.  The Caenorhabditis elegans F-box protein SEL-10 promotes female development and may target FEM-1 and FEM-3 for degradation by the proteasome.

Authors:  Sibylle Jäger; Hillel T Schwartz; H Robert Horvitz; Barbara Conradt
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-11       Impact factor: 11.205

Review 9.  Neddylation dysfunction in Alzheimer's disease.

Authors:  Yuzhi Chen; Rachael L Neve; Helena Liu
Journal:  J Cell Mol Med       Date:  2012-11       Impact factor: 5.310

10.  Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer.

Authors:  Shahab Akhoondi; Linda Lindström; Martin Widschwendter; Martin Corcoran; Jonas Bergh; Charles Spruck; Dan Grandér; Olle Sangfelt
Journal:  Breast Cancer Res       Date:  2010-12-01       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.